CG
BSX icon

Clinton Group’s Boston Scientific BSX Stock Holding History

Clinton Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23,298
Closed -$578K – 370
2017
Q4 		$578K Buy
+23,298
New +$643K 0.05% 308
2017
Q2 		– Sell
-21,789
Closed -$542K – 597
2017
Q1 		$542K Sell
21,789
-41,025
-65% -$998K 0.03% 609
2016
Q4 		$1.36M Sell
62,814
-598,551
-91% -$13.1M 0.08% 301
2016
Q3 		$15.7M Buy
661,365
+597,256
+932% +$14.2M 0.74% 9
2016
Q2 		$1.5M Buy
64,109
+24,161
+60% +$523K 0.07% 360
2016
Q1 		$751K Buy
39,948
+25,858
+184% +$454K 0.05% 496
2015
Q4 		$260K Buy
+14,090
New +$252K 0.02% 664
2015
Q3 		– Sell
-20,320
Closed -$360K – 679
2015
Q2 		$360K Buy
+20,320
New +$363K 0.05% 435

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Clinton Group's BSX Position: Q1 2018 in Review

Clinton Group sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 23,298 shares — an estimated $578K sold.

Clinton Group first reported a position in BSX in Q2 2015 and held it in 8 quarters. The position peaked at $15.7M in Q3 2016. 634 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

  • Clinton Group reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
  • Clinton Group sold 23,298 Boston Scientific shares in Q1 2018, an estimated $578K.
  • Clinton Group first reported a position in Boston Scientific in Q2 2015 and held it in 8 quarters.
  • Clinton Group's Boston Scientific position peaked at $15.7M in Q3 2016.
  • 634 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on Clinton Group's 13F filing for Q1 2018, filed 14 May 2018.